Project Details
| Short title | BAT-7104-002-CR |
|---|---|
| Acronym | BAT-7104-002-CR |
| Status | Active |
| Effective start/end date | 23/06/22 → 30/03/27 |
CTU: A Phase 1, Multi-Center, Open-Label Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT7104 in Patients with Advanced Solid Tumours
- Park, John (Primary Chief Investigator)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research